The EudraVigilance Medicinal Products Dictionary (EVMPD) was developed by the European Medicines Agency (EMA) to aid pharmacovigilance activities in the European Economic Area and was designed to support the collection, reporting, coding, and evaluation of both investigational and authorized medicinal product information in a standardized manner.
On July 1, 2001, as a step in implementing new pharmacovigilance legislation in the EU, the EMA published the format in which pharmaceutical companies will need to submit information on all of their drugs authorized or registered—by whatever authorization route—in the EU. The new format will go into effect on July 2, 2012.
To find more information please click here: Medical Translation Insight: Complying with EMA's new requirement for medicinal product information
No comments:
Post a Comment